Fig. 3From: Modified response evaluation criteria in solid tumors is superior to response evaluation criteria in solid tumors for assessment of responses to sorafenib in patients with advanced hepatocellular carcinomaKaplan–Meier analysis of overall survival. The log-rank test showed significant differences between the four groups (P < 0.0001) categorized according to mRECISTBack to article page